Endoca Australia is transitioning to a new identity, Aura Therapeutics, as the Sydney-based company expands its product offerings to meet the demands of the Australian market.
Head of operations Leigh-Ann Nazareth said: "The Endoca brand, originating from Europe and primarily focused on CBD products, no longer aligns with our vision to offer a diverse product portfolio, including dried flower, oils, vapes, soft-gel caps, and extracts tailored specifically for the Australian market."
She also noted that the company has moved away from Endoca supply entirely, which means "retaining the brand name is no longer commercially viable".
The name change will take place over the coming month, with managing director Tom Fay confirming it will be "business as usual" throughout the process.
He added: "We're focusing on a smooth transition with our key industry partners, clinics, health professionals, and patients.
"We highly value our partnerships in the Australian cannabis sector and will maintain our collaboration to ensure affordable access to high-quality medicine."
Lisa Varley will continue in her role as a corporate advisor to Aura Therapeutics.
